Have taken a modest stake in RWS, which has niche market in patent translations into various languages for blue chip customers. Market cap approx 120M, but has 20M cash in the bank and excellent track record on profit/cash generation. Shares have been punished recently because of a forthcoming European Directive which will affect need for some translations. IMO the drop in the price from 360p to the 3 I paid looks overdone, but we shall see. Might be worth a look for those interested in medium term investing. Always DYOR

Excellent trading update at AGM yesterday. Recent acqusition CTi bought on 10x expected 2015 EBITDA earnings of $7M - unaudited figs suggest $8.5M. No further payments due to vendors and this business very much in RWS comfort zone (unlike previous purchase inovia a couple of years or so ago). Augurs well for 2016, albeit around half of CTi sales said to be "lumpy", so 2016 may see a dip. With borrowed money very cheap, however, a much better investment for them than cash on deposit. Should also give cross selling opportunities with RWS business in Europe. Core business plodding on nicely and inovia now seems fully integrated. Weak sterling an added bonus in the short term at least. I like, but always dyor.

Bit disappointing to see sale of most of sizeable options exercised by CEO, but nevertheless his holding now increases from previous very modest level to over 220K shares. Exec chairman and 42% shareholder Andrew Brode is on the Remuneration Committee and imo keeps fair rein on pay for his co-directors.

Very strong half year trading update. Recent acquisition looking excellent and medium/long term story intact. I have top sliced a few held outside ISA, but will buy back in new ISA year on any weakness.Always dyor.

Record year to 30th Sept, helped by US acquisition and over 80% of revenues now non sterling. Net debt £1.5M after new loan $45M end of 2015 shows superb cash generation and likely increase in dividend again this year. AIM listed, so should be free from IHT once held for two years - held mine a lot longer! Always dyor.

Superb results. Profit and dividend increased every year since flotation and cash generation from operations this year almost £30M. Think it was Warren Buffet's pal Charlie Munger who said you make your real money by waiting and RWS is a good example of that for me, but always dyor.

Another excellent set of interim figures and latest (big) acquisition has started well. Int Divi up 13% looks likely to maintain record of increases every year since flotation.

Chairman Andrew Brode's other quoted interest LTG attracting a lot of attention of late, but more mature business RWS has trading update due soon, which if past performance anything to go by is unlikely to disappoint. They have been a fantastic investment over last ten years, but always dyor

Came sooner than last year, but they say good numbers take less time to add up than bad. Not many updates as positive as this one, from the normally quite cautious Andrew Brode. Mine still locked away, but always dyor.

Wow!

Big volatility in share price of late and now we know why. Large placing to help with large acquisition. Sharp intake of breath, but RWS has not put a foot wrong so far, so I am keeping mine. Always dyor

Splendid results to 30th Sept., upstaged by large acquisition of Moravia since. Jury out on that one yet, but with other business trading strongly at the start of the new financial year and Moravia hoping to "immediately and highly" add to earnings, mine locked away in the ISA. Always dyor.

One of Questor's favourites and tipped as a buy.

Half year results show back on track after recent concern over forex, albeit RWS now becoming a large animal to manage. Lot to digest with Moravia acquisition, but senior management changes across the group suggest Andrew Brode still on the ball. 15% increase in interim divi higher than expected and a sign of confidence. Debt looks like it can be paid down fairly quickly. Always dyor.